T/CAQ 29007-2023 Quality Chinese medicinal herbs: Aiye (rhizome of Artemisia argyi)
T/CAQ 29007-2023 Quality Chinese medicinal herbs: Aiye (rhizome of Artemisia argyi)
Basic Information
Scope
Scope: This document specifies the requirements for quality mugwort herbal medicines, testing methods, inspection rules, judgment rules, labeling, packaging, and storage. This document is applicable to the judgment of quality mugwort herbal medicines. Main technical content: The quality herbal medicines defined in this document are those that meet the management regulations such as the "Good Agricultural Practice for Chinese Herbal Medicines" (GAP) and the "Good Agricultural Practice for Medicinal Plants and Harvesting" (GACP) during the production process, with their indicators exceeding the requirements of the *Chinese Pharmacopoeia* (2020 Edition), and their limits for exogenous pollutants and endogenous toxic substances being lower than those in the *Chinese Pharmacopoeia* (2020 Edition). To meet the market demand for mugwort, this document proposes quality indicators for quality mugwort that exceed those in the *Chinese Pharmacopoeia* (2020 Edition), and limits for pesticide residues, heavy metals and harmful elements, and mycotoxins that are lower than those in the *Chinese Pharmacopoeia* (2020 Edition). On the basis of qualified mugwort herbal medicines, this document adds quality detection indicators such as alcohol-soluble extracts, 233 types of pesticide residues and their maximum residue limits, heavy metals and harmful elements, and mycotoxins, and increases the content of indicative (effective) components, making their quality superior to that of qualified mugwort herbal medicines.